TIMP3 and prostate carcinoma: Furthermore, as shown in Table 5, we observed a significant association between the TIMP3 rs9862 gene polymorphism and clinical status (clinical T stage and total score upgrade) in prostate cancer patients (p = 0.030 and 0.002, respectively).